Cite

HARVARD Citation

    Bekker, A. et al. (2022). Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates. Journal of acquired immune deficiency syndromes. p. . [Online]. 
  
Back to record